Roche is on the hunt for some first-in-class projects — and, with the help of a new partner, it’s starting from scratch. The pharma giant has tapped PhoreMost, a small biotech working out of Cambridge, UK, for a target discovery pact in which PhoreMost will deploy its screening platform toward
This content was originally published here.
